NCT02049970View on ClinicalTrials.gov

Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Sequelae of Fracture of Forearm and Upper Arm
Interventions
DRUG

dexmedetomidine

1 ml 100 mcg dexmedetomidine+ 15 ml 0.25 % bupivacaine are applied around brachial plexus

DRUG

bupivacaine

30 ml 0.25 % bupivacaine is applied around brachial plexus

Trial Locations (1)

38039

Erciyes University Medical Faculty, Kayseri

All Listed Sponsors
lead

TC Erciyes University

OTHER

NCT02049970 - Effect of the Addition of Dexmedetomidine to Bupivacaine During Supraclavicular Brachial Plexus Blockade | Biotech Hunter | Biotech Hunter